FIELD: medicine, pharmaceutics.
SUBSTANCE: described is novel polymorphic form B N-[3-tret-butyl-1-(3-chlor-4-hydroxyphenyl)-1H-pyrazol-5-yl]-N'-{2-[(3-{2-[(2-hydroxyethyl)sulfanyl]phenyl}-[1,2,4]triazolo[4,3-a]pyridin-6-yl)sulfanyl]benzyl]}carbamide, method of its obtaining.
EFFECT: possibility to apply composition in treatment of various states, especially in treatment of inflammatory conditions, such as chronic obstructive lung disease.
4 cl, 12 ex, 9 tbl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| UREA DERIVATIVES AND THERAPEUTIC USE THEREOF IN TREATING, AMONG OTHER THINGS, RESPIRATORY TRACT DISEASES | 2011 |
|
RU2586223C2 |
| KINASE INHIBITORS | 2013 |
|
RU2637944C2 |
| DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE-1-YL-UREA AND THEIR USE IN TREATMENT, INTER ALIA, DISEASES OF RESPIRATORY TRACT | 2011 |
|
RU2586333C1 |
| CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
| TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING | 1996 |
|
RU2161158C2 |
| KINASE INHIBITORS | 2012 |
|
RU2623734C9 |
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
| MTOR KINASE INHIBITORS FOR ONCOLOGIC INDICATIONS AND DISEASES ASSOCIATED WITH MTOR/PI3K/AKT BY METABOLISM | 2009 |
|
RU2692796C2 |
